Home > Ocugen Stock Is Rallying, Outperforming Moderna and Other Vaccine Companies

Ocugen Stock Is Rallying, Outperforming Moderna and Other Vaccine Companies

Ocugen’s stock price increased by nearly 18.5% yesterday, and almost 33.4% in the past five days. The vaccine company is rapidly outperforming other healthcare stocks.

This year, many vaccine companies have been in the spotlight after successfully developing Covid-19 vaccines. The bullish run is now surprisingly coming from yet another stock – the Indian Ocugen, and the popular stocks like Moderna failed to keep up with yesterday’s rally.

Let’s find out why Ocugen’s shares are flying past its competitors.

How & Where to Buy Ocugen Stock Online

Ocugen (NASDAQ: OCGN) shares can be purchased after registering with an online broker. Our top picks are:


eToro is one of the world's leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It's social copy trading features make it a great choice for those getting started.

Register with eToro instantly


Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.

Register with Webull instantly

What Is Ocugen?

Ocugen is an Indian healthcare company that partnered with Bharat Biotech to develop the Covid-19 vaccine. Recently, the company has been working on a vaccine for children.

Should I Buy Ocugen Today?

Ocugen has just received the green light from the Indian government regarding the Covid-19 vaccine for children between 2 and 18 years old. It was developed in collaboration with Bharat Biotech, and the approval led to a massive bullish price rally. The stock increased more than popular companies’ stock, such as Moderna.

Ocugen is currently in a bullish run, as indicated by its 50-day and 200-day moving average. Yet, its future is uncertain as the stock has previously found resistance at $10. If it pushes higher, the bulls may enjoy their party, while the bears would like to see the stock being rejected, which means it will start to drop once again towards the $6 support level.

Ocugen Price Prediction 2021

Currently trading at $9.11, Ocugen’s price may soon break its resistance level – or, alternatively, go back to the support level of $6. Yet, analysts are bullish, offering a high estimate of $15.   

Trade/invest in stocks with just $50
Invest for dividends and get payout on stocks on Ex-Dividend day
Over 11 payment methods, including PayPal
Open my Account

We use cookies to personalise content & ads, provide social media features and offer you a better experience. By continuing to browse the site or clicking "OK, Thanks" you are consenting to the use of cookies on this website.